Advertisement

Topics

Companies Related to "BioElectronics Announces Health Economics Study" [Most Relevant Company Matches] RSS

03:22 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "BioElectronics Announces Health Economics Study" found in our extensive corporate database of over 50,000 company records.

Showing "BioElectronics Announces Health Economics Study" Companies 1–25 of 7,200+

Extremely Relevant

BioElectronics Corp.

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.


BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.

Relevant

Office of Health Economics

The Office of Health Economics provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors. The OHE has an international reputation, for the quality and independence of its research, which is safeguarded through our Policy Board and Editorial Board


Lappeenranta University of Technology

Lappeenranta University of Technology (LUT) was established in 1969 as a national university of technology. LUT, as well as the 19 other universities in Finland are all state-run and financed by the Ministry of Education. Lappeenranta University of Technology is specialised in technology and economics. About 5000 students study in the various degree programmes offered by the university, and about ...

European Health Economics

European Health Economics SAS is an international consulting company specializing in economic evaluation of health interventions (pharmaceuticals, medical devices, procedures) and executive courses in the field of economic evaluation of health technologies. The company was founded in 1998 as "HDI France" and was transformed into European Health Economics SAS (EHE) at the beginning of 2003

Medical Economics

In 1923, Medical Economics magazine was created to help busy physicians cope with the business side of medicine, the nonclinical problems associated with running a private, office-based practice.Today, Medical Economics continues to live up to that challenge, and to its responsibility as the best-read journal in the physician marketplace: informing, educating, and assisting busy primary-care docto...

The Zitter Group

The Zitter Group was founded in San Francisco in February 1989. Over the years, as the managed care market has evolved, so has The Zitter Group. When the company first opened its doors, patient outcomes and health economics were just emerging as important issues. The Zitter Group pioneered the national dialogue between payers and manufacturers, producing the industry’s first meeting on pharmacoe...

PG Economics Ltd

PG Economics Limited is a specialist provider of advisory and consultancy services to agriculture and other natural resource-based industries. Our specific areas of specialisation are plant biotechnology, agricultural production systems, agricultural markets and policy.The Company's two directors are Peter Barfoot and Graham Brookes who formed PG Economics in 1999. Both have worked at senior posit...

Health Economics Research Institute

Institute for Health Economics and Policy

RWTH Aachen University

RWTH Aachen University,Here, you will discover numerous opportunities offered at this university in the areas of research, teaching and study.The RWTH Aachen is characterised by its strength in science and engineering education. It also provides a wide range of subjects in Economics, Arts and Humanities and Medicine with an emphasis on intensive interaction between all disciplines. The focus on in...

Global Health Economics & Outcomes Research

Nil

ACRO

Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

Dr.ROBERT SCALES

Robert Scales, Ph.D., is a native of Scotland, but he has resided in the Southwest for the past twenty years. He has his doctorate degree in education and he holds a faculty position in the School of Medicine at the University of New Mexico, where he conducts research and teaches motivational interviewing (MI). Currently, he is the Director of Cardiac Rehabilitation and Wellness at a hospital in...

Ingres Corporation

Ingres is the leading open source database management company. We are the world’s second largest open source company and the pioneer of the New Economics of IT, providing open source solutions at dramatically reduced cost than proprietary software vendors. As a leader in the New Economics of IT, Ingres delivers low cost and accelerated innovation to m...

Applied Logic Associates

Applied Logic Associates, Inc. (ALA) is a consulting firm for pharmaceutical, medical device and biotechnology companies in the areas of Clinical/Regulatory Affairs, Clinical Study Management, Information Management, Biostatistical Analysis and Health Care Economics. For 10 years, ALA has served as a vital link in bringing new products to market. ALA provides cost-effective and timely services fro...

Prescription Dispensing Laboratories

Prescription Dispensing Laboratories announces a major discovery related to the use of calcium channel blockers for the noninvasive, topically applied transdermal treatment of Peyronie's Disease, Dupuytren's Contracture, Plantar Fibromatosis and related connective tissue disorders worldwide patents are pending). Accept no imitations. Transdermal verapamil is available only from PDLABS.A comparison...

UMR GAEL

The GAEL (Applied Economics Laboratory of Grenoble) Research Unit is an INRA and Pierre Mendès France University Laboratory. Its mission is to produce and disseminate scientific knowledge on innovation, the environment and industrial organizations. The laboratory employs about fifteen permanent researchers and lecturer-researchers and many PhD and post-doctoral students. Each of the laboratory's ...

Brighton Health Group

Brighton Health Group is a healthcare enterprise dedicated to developing innovative products that align the interests of healthcare providers, employers and other plan sponsors, families, and payers. By creating a sustainable business model based on a shared reward system, Brighton Health Group collaborates with stakeholders to align economics for o...

Boston Health Economics, Inc

Boston Health Economics (BHE) is a full-service outcomes research organization specializing in the economic evaluation of pharmaceuticals, medical devices, and disease management programs. BHE delivers high-quality, objective consulting services to inform strategy and enhance value.Founded in 1996, BHE is an independent, full-service outcomes research organization. Our core services center around ...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

Probably Relevant

Oxford Outcomes

Oxford Outcomes is an international consultancy which specialises in patient-reported outcomes, health economics, epidemiology and health programme evaluation. The company has offices in Oxford and Vancouver, as well as a new office opened in Washington D.C. in June 2006. The consultancy team isled by Diane Wild, Andrew Briggs, Adrian Levy, Maggie Tabberer, Kathy Beusterien and Mark Sculpher, supp...


More From BioPortfolio on "BioElectronics Announces Health Economics Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks